Prevent & Potentially Treat Ebola

This is an article about preparing for Ebola. Whilst I am not a "prepper", I do believe in the 7 Ps, a British Army adage for Proper Planning and Preparation Prevents Piss Poor Performance. Ebola hasn't gone away; there is acurrent outbreak in the Democratic Republic of Congo.

In the event of an Ebola pandemic I am prepared. to face such a lethal threat. I am in no way making a claim to be able to cure Ebola. The best "cure" seems to be a blood transfusion from an Ebola survivor, much like the original innoculation with small pox.  I do however believe that natural medicine has a lot to offer to prevent and treat Ebola.

The reality of pandemics

There have been many global pandemic killers. Notably, The Spanish Flu (1918 – 1919) killed 50 to 100 million people worldwide in less than 2 years. The Black Death (1340 – 1771) killed 75 million people worldwide. Malaria (1600 – today) kills about 2 million people per year. Smallpox (430 BC? - 1979) has killed more than 300 million people worldwide in the 20th century alone and AIDS (1981 – today) has killed 25 million people worldwide.

Many people believe that another pandemic is way overdue. I personally believe that "the big one" is coming. We have destroyed our natural immunity by overusing antipyretics to suppress fevers, overprescribing antibiotics, by adopting an ever growing vaccination schedule and by overusing antibacterials in our homes. We live in a "civilised" society where 63% are overweight or obese, 1/3 of our children suffer from chronic disease such as eczema or asthma and food allergy and autoimmune disease is on the rise. If peanuts kill our children and our immune systems are so stupid that they can't differentiate between a foreign invader and our own cells, then how can we possibly handle a global killer? How can we fight Ebola?

Not meaning to be a scaremonger, it seems that the only way is to contain it. With infected people getting on planes, it is only a matter of time. Whilst this current epidemic may well indeed peak and then trough, the fact remains, the world is currently being faced with the deadliest Ebola outbreak on record and Western Medicine has no available treatment. The only chance we have is to boost our natural immunity.

Ebola virus disease (EVD), Ebola hemorrhagic fever (EHF) or simply Ebola is a disease caused by the ebolavirus. The first known outbreak of Ebola virus disease was in 1976. The disease typically occurs in outbreaks in tropical regions of Sub-Saharan Africa. From 1976 through 2013, the World Health Organisation reported 1,716 confirmed cases. The largest outbreak to date is the ongoing 2014 West Africa Ebola virus outbreak, which is affecting Guinea, Sierra Leone, Liberia and Nigeria. As of 10 October, 8,376 suspected cases have been identified, with 4,024 deaths with predictions in the millions. Dire new estimates are saying that as many as 550,000 to 1.4 million cases of the Ebola virus could emerge in Liberia and Sierra Leone alone, in four months.

Signs and symptoms of Ebola
Signs and symptoms begin suddenly with an influenza-like stage characterised by fatigue, fever, headaches, and pain in the joints, muscles and abdomen. Vomiting, diarrhoea, and loss of appetite are common. Less common symptoms include sore throat, chest pain, hiccups, shortness of breath, and trouble swallowing.

Incubation period
The average time between contracting the infection and the start of symptoms (incubation period) is 8 to 10 days, but can vary between 2 and 21 days. In about 5-50% of cases, skin manifestations may include a maculopapular rash (a flat, area on the skin that can be red in white skinned people covered with small joined bumps). Early symptoms of EVD may be similar to those of malaria, dengue fever, or other tropical fevers, before the disease progresses to the bleeding phase that is why it may be so easily misdiagnosed

The bleeding phase
Now called the secretory phase but we have all seen enough zombie movies to imagine what this stage looks like. In 40–50% of cases, bleeding from puncture sites and mucous membranes (e.g., gastrointestinal tract, nose, vagina, and gums) occurs. In the bleeding phase, which typically begins five to seven days after first symptoms, internal and subcutaneous bleeding may present itself in the form of reddened eyes and bloody vomit. Bleeding into the skin may create petechiae, purpura, ecchymoses, and haematomas. Sufferers cough up blood, vomit it and excrete it in their stool.

Laboratory tests
Changes on laboratory tests as a result of Ebola virus disease include a low platelet count, an initially decreased white blood cell count followed by an increase in the white blood cell count and elevated levels of the liver enzymes. Heavy bleeding is rare and is usually confined to the gastrointestinal tract. In general, the development of bleeding symptoms often indicates a worse prognosis and this blood loss can result in death. All people infected show some signs of circulatory system involvement, including impaired blood clotting. If the infected person does not recover, death due to multiple organ dysfunction syndrome occurs within 7 to 16 days (usually between days 8 and 9) after first symptoms.

Cause of Ebola
Ebola virus is in the genus Ebolavirus, family Filoviridae, order Mononegavirales. The four disease-causing viruses are Bundibugyo virus (BDBV), Sudan virus (SUDV), Taï Forest virus (TAFV), and one called, simply, Ebola virus (EBOV, formerly Zaire Ebola virus).

Transmission of Ebola

  • Human-to-human transmission occurs only via direct contact with blood or body fluid from an infected person (including an infected dead body), or by contact with objects contaminated by the virus, particularly needles and syringes. Other body fluids that transmit ebolaviruses include saliva, mucus, vomit, faeces, sweat, tears, breast milk, urine and semen. Entry points include the nose, mouth, eyes, or open wounds, cuts and abrasions.
  • Transmission from other animals to humans occurs only via contact with, or consumption of, an infected mammal, such as a fruit bat or ape.
  • The symptoms limit a person's ability to spread the disease as they are too sick to travel during the infectious stage of the disease. As transmission via air is generally ruled out, the possibility of transmission between non-seat-mate airline passengers is also generally ruled out.
  • Because dead bodies are still infectious, traditional burial rituals may spread the disease. Nearly two thirds of the cases of Ebola infections in Guinea during the 2014 outbreak are believed to have been contracted via unprotected (or unsuitably protected) contact with infected corpses during certain Guinean burial rituals.
  • Semen may be infectious in survivors for up to 7 weeks.
  • It is not entirely clear how an outbreak is initially started. The initial infection is believed to occur after an ebolavirus is transmitted to a human by contact with an infected animal's body fluids.
  • One of the primary reasons for spread is that the health systems in the part of Africa where the disease occurs function poorly. Medical workers who do not wear appropriate protective clothing may contract the disease. Hospital-acquired transmission has occurred in African countries due to the re-use of needles and lack of universal precautions. Some healthcare centres caring for people with the disease do not even have running water.

Bats are considered natural reservoir

  • Bats are considered the most likely natural reservoir of Ebola. Antibodies against Zaire and Reston viruses have been found in fruit bats in Bangladesh. Fruit bats are also eaten by people in parts of West Africa where they are smoked, grilled or made into a spicy soup.
  • Plants, arthropods, and birds were also considered. Of 24 plant species and 19 vertebrate species experimentally inoculated with EBOV, only bats became infected
  • In the wild, transmission may occur when infected fruit bats drop partially eaten fruits, then animals such as gorillas and duikers (A duiker is a small to medium-sized antelope native to Sub-Saharan Africa) feed on these fallen fruits. This chain of events forms a possible indirect means of transmission from the natural host species to other animal species.Traces of EBOV were detected in the carcasses of gorillas and chimpanzees during outbreaks in 2001 and 2003, which later became the source of human infections.
  • Transmission between natural reservoir and humans is rare, and outbreaks are usually traceable to a single case where an individual has handled the carcass of gorilla, chimpanzee or duiker.

Pathophysiology of Ebola
This subject is useful in the attempt to understand what is going on with a view to potentially inhibit the viral replication with compounds found in natural sources. Cells lining the inside of blood vessels (endothelial cells), macrophages, monocytes and liver cells are the main targets of infection. After infection, a secreted glycoprotein, known as the Ebola virus glycoprotein (GP), is synthesised. Ebolavirus replication overwhelms protein synthesis of infected cells and host immune defenses.

The GP forms a trimeric complex, which binds the virus to the endothelial cells. The sGP forms a dimeric protein that interferes with the signaling of neutrophils, a type of white blood cell, which allows the virus to evade the immune system by inhibiting early steps of neutrophil activation. These white blood cells also serve as carriers to transport the virus throughout the entire body to places such as the lymph nodes, liver, lungs and spleen. Ebolavirus has demonstrated the ability to blunt the human immune system's response to viral infections by inhibiting the production of the interferon-beta protein.

The presence of viral particles and cell damage resulting from budding causes the release of chemical signals (TNF-α, IL-6, IL-8, etc.), which are the signaling molecules for fever and inflammation. The damage to human cells, caused by infection of the endothelial cells, results in a loss of blood vessel integrity. This loss in vascular integrity is furthered with synthesis of GP, which reduces specific integrins responsible for cell adhesion to the inter-cellular structure, and damage to the liver, which leads to improper clotting.

Infection control

  • The Ebola virus is only transmitted via direct contact with the bodily fluids of an infected person or animal. It is recommended that the bodies of people who have died from Ebola be buried or cremated with proper care. Direct contact with the body of the deceased patient should be avoided.
  • The risk of transmission is increased amongst Ebola caregivers. Recommended measures when caring for people infected with Ebola include barrier-isolation, sterilising equipment and surfaces, and wearing protective clothing including masks, gloves, gowns and goggles. Protective measures include avoiding direct contact with infected people and regular hand washing using soap and water.
  • Bush meat, an important source of protein in the diet of some Africans, should be handled with appropriate protective clothing and thoroughly cooked before consumption.
  • Airline crews are instructed to follow a certain isolation procedure should anyone exhibit symptoms resembling the Ebola virus disease??
  • Ebolaviruses can be eliminated with heat (heating for 30 to 60 minutes at 60°C or boiling for 5 minutes). Alcohol-based products, detergents, bleach and other suitable disinfectants at appropriate concentrations can be used as disinfectants on surfaces.

Quarantine, also known as enforced isolation, is usually effective in decreasing spread. Governments often quarantine areas where the disease is occurring or individuals who may be infected.

Contact tracing
Contact tracing is regarded as important to contain an outbreak. It involves finding everyone who had close contact with infected individuals and watching for signs of illness for 21 days. If any of these contacts comes down with the disease, they should be isolated, tested, and treated. Then repeat the process by tracing the contacts' contacts.

Western Medical Treatment
Standard support

  • No ebolavirus-specific treatment is currently approved.
  • Survival is improved by early supportive care with rehydration and symptomatic treatment.
  • Supportive treatment may include management of pain, nausea, fever and anxiety, as well as rehydration via the oral or by intravenous route. IV blood transfusions may also be used.
  • Other regulators of coagulation have also been tried including heparin in an effort to prevent disseminated intravascular coagulation and clotting factors to decrease bleeding.
  • Antimalarial medications and antibiotics are often used before the diagnosis is confirmed though there is no evidence to suggest such treatment is in any way helpful and in fact may be detrimental.

Intensive care
In the developed world intensive care is used. This may include maintaining blood volume and electrolytes balance as well as treating any bacterial infections that may develop. Dialysis may be needed for kidney failure while extracorporeal membrane oxygenation (ECMO) or extracorporeal life support (ECLS) may be used to keep the patient alive in the event of lung dysfunction.

The disease has a high mortality rate which varies between 25 percent and 90% of those infected. As of September 2014, information from WHO puts the average mortality at 50%. Supportive care to prevent dehydration may reduce the fatality rate significantly.

If an infected person survives, recovery may be quick and complete. Prolonged cases are often complicated by the occurrence of long-term problems, such as inflammation of the testicles, joint pains, muscle pains, skin peeling or hair loss. Eye symptoms, such as light sensitivity, excess tearing, iritis, iridocyclitis, choroiditis and blindness have also been described. EBOV and SUDV may be able to persist in the semen of survivors for up to seven weeks, which could give rise to infections and disease via sexual intercourse.

A number of experimental treatments are being studied. In the United States, the Food and Drug Administration (FDA)'s animal efficacy rule is being used to demonstrate reasonable safety to obtain permission to treat people who are infected with Ebola. It is being used because the normal path for testing drugs is not possible for diseases caused by dangerous pathogens or toxins. On 12 August 2014 the WHO released a statement that the use of not yet proven treatments is ethical in certain situations in an effort to treat or prevent the disease.


Ebola is a Filovirus from the family Filoviridae
The family Filoviridae include Ebola virus and Marburg virus. Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever. Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90%.

From a naturopathic perspective one must look to match the pharmacological actions of drugs using natural compounds found in foods and herbs.

A number of antiviral medications are being studied.

  • Favipiravir, an anti-viral drug against RNA viruses, approved in Japan for stockpiling against influenza pandemics, appears to be useful in a mouse model of Ebola. On 4 October 2014, it was reported that a French nun who contracted Ebola while volunteering in Liberia was cured with Favipiravir treatment
  • BCX4430, a novel synthetic adenosine analogue, is a broad-spectrum small molecule antiviral drug developed by BioCryst Pharmaceuticals and undergoing animal testing as a potential human treatment for Ebola by USAMRIID. The drug has been approved to progress to Phase 1 trials, expected late in 2014.The drug is used to treat filovirus infections such as Ebola virus disease.
  • Brincidofovir, another broad-spectrum antiviral drug, has been granted an emergency FDA approval as an investigational new drug for the treatment of Ebola, after in vitro tests found it to be effective against Ebola virus. It has subsequently been used to treat the first patient diagnosed with Ebola in Texas USA, after he had recently returned from Liberia. The patient subsequently died. Ebola however is an RNA virus and Brincidofovir inhibits replication of a variety of DNA viruses. So why? This procedure is standard in emergency situations and financially benefits the Pharmaceutical company that developed it.
  • Lamivudine, an antiviral drug which is usually used to treat HIV / AIDS, was reported in September 2014 to have been used successfully to treat 13 out of 15 Ebola-infected patients by a doctor in Liberia, as part of a combination therapy also involving intravenous fluids and antibiotics to combat opportunistic bacterial infection of Ebola-compromised internal organs. Western virologists have however expressed caution about the results and researchers at the NIH stated that lamivudine had so far failed to demonstrate anti-Ebola activity in vitro tests.
  • Other possible antivirals targeted against Ebola, including natural products made from the red algae, scytovirin (Scytovirin (SVN). Scytonema varium secretes the broad-spectrum antiviral protein scytovirin which can inactivate both the HIV virus, and Ebola virus. The other natural product being studied is griffithsin, from the New Zealand red algae species, Griffithsia sp.
  • Finally the synthetic drugs including FGI-103, FGI-104, FGI-106, dUY11 and LJ-001, and other newer agents.

Other experimental treatments against Ebola

Selective oestrogen receptor modulators (SERMs) and Ebola
Two selective oestrogen receptor modulators (SERMs) used to treat infertility and breast cancer including clomiphene and toremifene, have been found to which act as potent inhibitors of EBOV infection. Clomiphene and toremifene have been found to inhibit the progress of Ebola virus in vitro as well as in infected mice. Ninety percent of the mice treated with clomiphene and fifty percent of those treated with toremifene survived the tests.

Melatonin and Ebola
Melatonin has also been suggested as a potential treatment for Ebola based on promising in vitro results.

Ion channel blockers and Ebola
A 2014 study found that three ion channel blockers used in the treatment of heart arrhythmias, amiodarone, dronedarone and verapamil, block the entry of Ebola virus into cells in vitro.

ZMapp and Ebola
ZMapp is a monoclonal antibody vaccine. The limited supply of the drug has been used to treat a small number of individuals infected with the Ebola virus. Although some individuals have recovered, the outcome is not considered statistically significant. ZMapp has proved effective in a trial involving Rhesus macaque monkeys.

Blood products
The WHO has stated that transfusion of whole blood or purified serum from Ebola survivors is the therapy with the greatest potential to be implemented immediately, September 2014, WHO issued an interim guideline for this therapy. Seven of eight people with Ebola survived after receiving a transfusion of blood donated by individuals who had previously survived the infection in an 1999 outbreak in the Democratic Republic of the Congo. This treatment, however, was started late in the disease meaning they may have already been recovering on their own and the rest of their care was better than usual however, health officials are looking into this treatment method as a matter of urgency.

As of September 2014, no vaccine was approved by the United States Food and Drug Administration (FDA) for clinical use in humans.

Simultaneous phase 1 trials of an experimental vaccine known as the NIAID/GSK vaccine commenced in September 2014. GlaxoSmithKline and the NIH jointly developed the vaccine, based on a modified chimpanzee adenovirus, and contains parts of the Zaire and Sudan ebola strains. If this phase is completed successfully, the vaccine will be fast tracked for use in West Africa. In preparation for this, GSK is preparing a stockpile of 10,000 doses.

Naturopathic Approaches to Prevent and Potentially Treat Ebola
The demand for plant-based medicines is growing as they are generally considered to be safer, non-toxic and less harmful than synthetic drugs.

Herbs are not pseudoscience
In the last decade alone, more than 20 newly approved drugs were derived from natural sources, including plants and microorganisms. It has been estimated that 50% of contemporary drugs are either directly extracted from plants or chemically derived from naturally occurring compounds. Notable examples include the opiates, which are derived from the latex sap of the opium poppy (Papaver somniferum). Another example is aspirin (acetylsalicylic acid), the world's first-ever synthetic drug. This commonly used analgesic and anti-inflammatory is derived from salicylic acid, a constituent found in willow (Salix spp.) and meadowsweet (Filipendula ulmaria). Aspirin has been called "the most popular painkiller in the world" and has shown efficacy in the prevention of colon cancer.

Oseltamivir/Tamiflu is a preeminent example of a conventional drug that is derived from the naturally occurring compound, shikimic acid. Oseltamivir inhibits neuraminidase, an influenza enzyme that facilitates viral release from infected cells, thus inhibiting viral repliaction. Tamiflu inhibits both influenza A and B, and is used to prevent and treat influenza in adults and children.The Chinese star anise Illicium verum, is the primary industrial source of shikimic acid, the key precursor to Tamiflu. Limited supplies of star anise and low yields of shikimic acid are limiting factors in oseltamivir production. Additional sources of shikimic acid include sweetgum fruit Liquidambar spp. and ginkgo Ginkgo biloba however, Illicium species contain the highest concentrations.

Traditional African medicine
Garcinia kola
I can't source this nut anywhere. Everyone is saying it has the most potential but none is selling it.

Garcinia kola or bitter kola is a tree that grows in the rain forests of west Africa. The fruit, seeds, nuts and bark of the plant have been used for centuries in folk medicine to treat ailments from coughs to fever. Garcinia kola is traditionally used by African medicinemen for its purgative, antiparasitic and antimicrobial properties. The seeds are used for bronchitis, throat infections, colic, head or chest colds, and cough. It is also used for liver disorders and as a chewing stick.

A preliminary study of the plant in the 1990s showed signs that it slows down multiplication of the Ebola virus in vitro. Extensive further testing is necessary to determine if this effect can be replicated in humans and other animals. However, pharmaceutical companies are reluctant to invest resources in the development of drugs against extremely rare tropical diseases.

Antiviral herbs that slow viral replication and boost natural immunity to prevent and treat Ebola
The following herbs (except ginseng) are in my Carahealth Immune Tonic I recommend taking this mix throughout any seasonal epidemic and certainly in the event of Ebola coming to a town near you.

Echinacea root Echinacea purpurea/angustifolia
Echinacea is anti-microbial, anticatarrhal, alterative and immunomodulator.Many of the compounds in echinacea stimulate various aspects of the immune system including macrophage and lymphocyte function. Natural killer cell activity is increased and there is an increase in interferon production and phagocytosis. It is effective against both bacterial and viral attacks. In general it may be used widely and safely.

Chai Hu 柴胡/Thorowax Bupleurum falcatum
Bupleurum is an antioxidant, antiseptic, antifungal, antiviral, immune stimulant. In Traditional Chinese Medicine TCM, Bupleurum is said to be bitter, pungent and cool and to enter the gallbladder, liver, pericardium and san jiao channels. Bupleurum clears less yang disorders such as fever, chills, vomiting and disorders of liver qi stasis. Bupleurum contains triterpene saponins or saikosides, also known as saikosaponins which display potent antiviral activity.

Barberry Berberis vulgaris
Barberry is antibacterial, antiviral, antipruritic, antirheumatic, antiseptic, appetiser, astringent, anticancer, cholagogue, diaphoretic, diuretic, expectorant, hepatic, laxative, ophthalmic, purgative, refrigerant, stomachic and tonic. It is indicated for correcting liver function and promoting the flow of bile. It ameliorates conditions such as gallbladder pain, gallstones and jaundice. As a bitter tonic with mild laxative effects, it is used with weak or debilitated people to strengthen and cleanse the system. An interesting action is its ability to reduce an enlarged spleen. It acts against malaria and is also effective in the treatment of protozoal infection due to Leishmania spp. Barberry contains a constituent called Berberine which is strongly anti-tumour, antibiotic, antispasmodic, immunostimulatory, carminative, cholerectic, hypotensive, uterine tonic, & and sedative. Berberine has showed some activity against fungal infections, candida, yeast, parasites and bacterial/viral infections. Saikosaponins, the main active constituents of Bupleurum have displayed immunomodulatory, hepatoprotective, antitumoor and antiviral activities.

Elder Sambucus nigra
Elder is antiinflammatory, aperient, diaphoretic, diuretic, emetic, emollient,expectorant, galactogogue, haemostatic, laxative, ophthalmic, purgative, salve and stimulant. Elder has been long been used for the treatment of influenza. The plant has been called "the medicine chest of country people". The aerial parts of the elder plant contain lectins that have notable carbohydrate-binding properties and are therefore often used to study influenza virus agglutination. The antiviral mechanisms of elder lectins are believed to involve rendering viruses nonfunctional by binding influenza virus hemagglutinin, its major viral surface protein that facilitates infection. Preclinical studies suggest that S. nigra (flowers and berry) may inhibit influenza virus types A and B by reducing hemagglutination of red blood cells and inhibiting viral replication. Elder contains a natural anthocyanin which acts to inhibit influenza neuraminidase, the enzyme that works to assist viral replication. Tamiflu for example is a neuroamindase inhibitor. Derived from a black elderberry extract, cyanidin-3-sambubiocide has been found to be a potent inhibitor of sialidase activity. The German Commission E Monographs, a therapeutic guide to herbal medicine, approve Sambucus nigra for cough and bronchitis, fevers and colds.

Astragalus/Huang Qi 黄芪 Astragalus membranaceus
Astragalus is an adaptogen, antibacterial, anticancer, cardiotonic, diuretic, febrifuge, hypoglycaemic, hypotensive, pectoral, tonic, uterine tonic and vasodilator. Huang Qi is commonly used in Chinese herbalism. The root is a sweet tonic herb that stimulates the immune system. Recent research has shown that the root can increase the production of interferon and macrophages and thus help restore normal immune function in cancer patients. Patients undergoing chemotherapy or radiotherapy recover faster and live longer if given Huang Qi concurrently. It increases the production of blood cells. In TCM, astragalus is said to tonify spleen & lung Qi, raise Spleen & Stomach Qi and is used to treat prolapse, tonify Wei Qi to boost the immune system, tonify Qi & blood due to loss of blood to treat postpartum fever. Astragalus is specific for chronic cough.

Lemon Balm Melissa officinalis
Lemon balm is antianxiety, antibacterial, antidepressant, antiemetic, antispasmodic, antiviral, aromatherapy, carminative, diaphoretic, digestive, emmenagogue, febrifuge, sedative and tonic. Lemon balm is known as a thymoleptic or mood elevating herb and raises the spirits and lifts the heart. Modern research has shown the plant contains anti-viral polyphenols, in particular these combat the herpes simplex virus which produces cold sores. It also acts to inhibit thyroid activity. An infusion of the leaves is used in the treatment of fevers and colds, indigestion associated with nervous tension, excitability and digestive upsets in children, hyperthyroidism, depression, mild insomnia, headaches. The essential oil contains citral and citronella, which act to calm the central nervous system and are strongly antispasmodic. The German Commission E Monographs, a therapeutic guide to herbal medicine, approve Melissa officinalis for nervousness and insomnia.

Other natural products that can help inhibit Ebola

Red algae inactivates the Ebola virus
Scytonema varium, secretes the broad-spectrum antiviral protein Scytovirin which can inactivate both the HIV virus and Ebola virus,

A protein called Griffithsin (GRFT) in the New Zealand red algae species, Griffithsia sp. Has also been show to inactivate the Ebola virus

Natural SERMs have the capacity to potentially inhibit the Ebola virus
As two selective oestrogen receptor modulators (SERMs) used to treat infertility and breast cancer including clomiphene and toremifene, have been found to which act as potent inhibitors of EBOV infection the use of natural SERMs apply.

First extracted from wine, resveratrol makes an excellent SERM type product that has many other health promoting benefits like anti-aging and cardiovascular.

Ellagic Acid
This extract of raspberries and pomegranate has true SERM-type effects. This is the only ingredient available to mimic the powerful effects of true SERMS (most others are ERM's, meaning they are not selective). Ellagic Acid also has anti-cancer effects, along with a host of other health benefits. It is commonly found in raspberries, strawberries, cranberries, walnuts, pecans and pomegranates. Buy and start taking an ellagic acid supplement usually in the form of a raspberry or pomegranate extract. Drink pomegranate juice.

Daidzein is a compound in soy that has weak oestrogenic activity. This is a classic partial oestrogen agonist. Eat tofu and tempeh, drink organic soy. If you have concerns about soy please read my article Oestrogen Dominance and Breast Cancer. In a nut shell, soy is life extending, the only issue with soy is GM or soy protein isolate. Remember our oldest citizens on the planet, the Okinawans, eat tofu everyday.

Flavones are flavonoids that act as natural SERMs. Sources of flavonoids include apples, apricots, blueberries, pears, raspberries, strawberries, black beans, cabbage, onions, parsley, pinto beans and tomatoes. Buy and take a flavonoid supplement,

Homeopathic Remedies to Prevent and Treat Ebola

I have these remedies available in a kit form and can post to you immediately please email me

Homeopathy has long been used to prevent and treat pandemic disease. The Spanish Influenza in 1918 was the most devastating influenza pandemic ever and was also called the Purple Death. It took place at the end of the First World War in 1918. The war took 9 million deaths, the Spanish Flu took 50 million deaths. It swept was more deadly than anything known before and comparable to the Black Death of 1348. Spreading like three tsunamis, the second and hardest wave hit during Autumn/Winter 1918. This was a time when America still had many of the best homeopaths, Boger, Boericke, Dewey and the young Grimmer were among them. So a high standard of homeopathic treatment of this dreaded pandemic was faithfully recorded there. In a meta study, more than 26,000 homeopathic patients were compared with 24,000 patients of the "old school" showing the much greater effectiveness of the homeopathic treatment. The homeopathic doctors had a consistent mortality rate of 1-3% among their patients, whereas the old school had a death toll of 25-30% of their patients. The homeopathic remedies most frequently used were gels, bry, arn, eup-per and ars.

Homeoprophylaxis – Prevention of Ebola
During an epidemic or as the case may be a pandemic, as a preventative Crotalus horridus 30C, one dose daily.

Suggested homeopathic treatments in the event of Ebola infection
If a person is infected, the remedies most commonly used would be the following. One dose every hour, but as the severity of the symptoms decrease, frequency is reduced. If no improvement is seen after 6 doses, a new remedy ought to be considered.

Crotalus horridus 30C
Is to be considered for when there is difficulty swallowing due to spasms and constriction of the throat, dark purplish blood, edema with purplish, mottled skin.

1. Crolatus horridus (rattlesnake venom)
2. Bothrops (yellow viper)
3. Lachesis (bushmaster snake)
4. Phosphorus
5. Merc. cor.
Please arrange a Skype consult with myself to educate you in how to prescribe these remedies. Please do not self-prescribe.

Crotalus horridus 30C – Is to be considered for when there is difficulty swallowing due to spasms and constriction of the throat, dark purplish blood, edema with purplish, mottled skin.

Lachesis mutus 30C – when there's delirium with trembling and confusion, hemorrhaging in any area, consider this remedy. Often, the person cannot bear tight or constricting clothing or bandages and feels better from heat and worse on the left side.

Mercurius corrosivus 30C – For copious bleeding, better when lying on the back with the knees bent up, delirium, headache with burning cheeks, photophobia, black swollen lip, metallic, bitter or salt taste in mouth.

Secale cornutum 30c – For thin, slow, painless oozing dark hemorrhage with offensive odor, cold skin and tingling in the limbs. The individual wants to be uncovered and feels WORSE from motion.

Echinacea 30C – For when there's sepsis or blood poisoning, fetid smelling discharges and enlarged lymph nodes

Bothrops Lanceolatus 30C – Is the remedy to think of when nervous trembling, difficulty articulating speech, sluggishness, swollen puffy face, black vomiting are present

Coconut water for hydration and the intravenous use of coconut water
Coconut is known as natures electrolyte replacement drink. It is a natural rehydrate and should be drunk in cases where dehydration exist such as resulting from the fever and bleeding phase of Ebola. Interestingly medical resources routinely used for intravenous hydration and resuscitation of critically ill patients may be limited in remote regions of the world. When faced with these shortages, physicians have had to improvise with the available resources, or simply do without. We report the successful use of coconut water as a short-term intravenous hydration fluid for a Solomon Island patient, a laboratory analysis of the local coconuts, and a review of previously documented intravenous coconut use. Campbell-Falck D1, Thomas T, Falck TM, Tutuo N, Clem K.The intravenous use of coconut water. Am J Emerg Med. 2000 Jan;18(1):108-11.

To purchase any remedies described in this article or to arrange a consultation contact Carina This email address is being protected from spambots. You need JavaScript enabled to view it..

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.